Bowen Therapy and McGill Stabilization Exercises in Chronic Low Back Pain
CompletedNot applicableNCT07694219
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This randomized controlled trial aims to compare the effectiveness of Bowen Therapy combined with McGill stabilization exercises versus Bowen Therapy alone in individuals with chronic nonspecific low back pain. The study will evaluate changes in pain intensity, lumbar range of motion, and functional disability over a four-week intervention period. It is hypothesized that the combined intervention will produce greater improvements in clinical outcomes than Bowen Therapy alone.
Study details
- Official title
- Comparison of Bowen Therapy and McGill Stabilization Exercises on Pain, Range of Motion, and Disability in Chronic Low Back Pain: A Randomized Controlled Trial
- Interventions
- Procedure: Bowen Therapy + McGill Stabilization Exercise
- Procedure: Bowen Therapy
- Sponsor
- Sehat Medical Complex
- Start date
- 2024-03-22
- Primary completion
- 2024-12-14
- Sex
- All
- Age range
- from 25 Years to 55 Years
- Results posted
- No results posted in this snapshot
- Countries
- Pakistan
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * With chronic localized low back pain lasting over three months * Without any signs of pain below the gluteal fold * Fulfills the recommended diagnostic criteria of nonspecific chronic low back pain. Exclusion Criteria: * Lumbar disc herniation * Lumbar canal stenosis * Spondylolisthesis * Spondylitis * Radiculopathy * Vertebral fracture * Neurological deficits * Pregnancy or radiating pain below the gluteal fold.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07694219